Used primarily in the treatment of Parkinson’s disease, this compound helps manage motor symptoms by stimulating dopamine receptors in the brain. It improves movement control, reduces tremors, and enhances overall daily functioning in patients. Additionally, it may be explored for use in restless legs syndrome due to its dopaminergic activity. The compound’s design allows for better selectivity and potentially fewer side effects compared to older dopamine agonists.